President Trump
Five things for pharma marketers to know: Monday, March 27, 2017
March 27, 2017Alexion names former Baxalta head as CEO; U.S. dollar drops after AHCA-fail; EMA advises suspension of 300 generic drugs by Indian drugmaker
Five things for pharma marketers to know: Friday, March 24, 2017
March 24, 2017Lilly to invest $850 million in the U.S.; President Trump gives GOP leaders ultimatum on healthcare bill; Pfizer, Merck KGaA receive FDA approval for Bavencio
New healthcare bill to negatively affect drugmakers: Moody's
March 17, 2017Per the credit ratings agency, more uninsured Americans will lead to less demand for healthcare services and treatments.
Five things for pharma marketers to know: Tuesday, March 14, 2017
March 14, 2017Pershing Square sells entire Valeant stake; FDA approves Novartis breast-cancer drug combo; Express Scripts asks Gilead to lower hep-C drug prices
Five things for pharma marketers to know: Friday, March 10, 2017
March 10, 2017Novartis' Gleevec shows long-term survival benefit in study; Novo Nordisk CEO considers small acquisitions; Merck KGaA to sell biosimilars unit
Five things for pharma marketers to know: Wednesday, January 25, 2017
January 25, 2017Novartis forecasts slower growth in 2017; Actelion reports trial failure for PAH drug; HHS nominee Tom Price denies conflict of interest claims
Five things for pharma marketers to know: Tuesday, January 24, 2017
January 24, 2017Endo settles pay-for-delay charges; Trump signs order withdrawing U.S. from TPP; administration considers Patrick Soon-Shiong for healthcare role
Healthcare communicators track Obamacare repeal debate
January 22, 2017Many healthcare comms leaders are paying close attention to the debate between "access" to healthcare versus making it a requirement, experts say.
